Financials
- Market Capitalization 527.6 M
- Employee 133
- Founded 2003
- CEO N/A
- Website www.sutrobio.com
- Headquarter California, United States
- FIGI BBG000R4V3P3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2864 | ARVN Arvinas, Inc. - Common Stock | 8.55 USD | -0.47% | +4.27% | +18.42% | -8.06% | 551.66 M USD | ||
| 2871 | STTK Shattuck Labs, Inc. - Common Stock | 6.90 USD | -4.96% | +5.99% | +69.12% | +731.33% | 529.10 M USD | ||
| 2913 | PRTA Prothena Corporation plc - Ordinary Shares | 9.85 USD | +1.76% | +2.50% | +15.07% | +49.92% | 515.68 M USD | ||
| 2923 | ZURA Zura Bio Limited - Class A Ordinary shares | 5.49 USD | +8.07% | +9.80% | +52.50% | +346.34% | 521.54 M USD |
Frequently asked questions about Sutro Biopharma, Inc. - Common Stock
What is the Sutro Biopharma, Inc. - Common Stock stock price today?
The current price of Sutro Biopharma, Inc. - Common Stock (STRO) is 31.84. Over the past 24 hours, the stock has changed by -0.90%. Follow the STRO chart for real-time price dynamics.
What is the stock ticker of Sutro Biopharma, Inc. - Common Stock?
Sutro Biopharma, Inc. - Common Stock trades under the ticker STRO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Sutro Biopharma, Inc. - Common Stock stock going up?
STRO has changed by +5.29% over the last week, +22.27% over the last month, and +83.09% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Sutro Biopharma, Inc. - Common Stock net income for the last quarter?
Sutro Biopharma, Inc. - Common Stock reported net income of -38.48 M for the last quarter. The previous quarter showed -46.76 M, which means net income changed by +17.70%.
How many employees does Sutro Biopharma, Inc. - Common Stock have?
As of the latest available data, Sutro Biopharma, Inc. - Common Stock has 133 employees. Workforce size can provide additional context about the company's scale and operations.
What is Sutro Biopharma, Inc. - Common Stock EBITDA?
Sutro Biopharma, Inc. - Common Stock EBITDA is -28.38 M, and its EBITDA margin is -195.4%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Sutro Biopharma, Inc. - Common Stock stock?
You can buy Sutro Biopharma, Inc. - Common Stock (STRO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Sutro Biopharma, Inc. - Common Stock stock?
Investing in Sutro Biopharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the STRO chart and related analysis on metatrader.com as part of your research.